Krishna Bhat
Impact in
- Genetics top 0.1%
- Glioma Diagnosis and Treatment
- Geriatrics and Gerontology top 0.5%
- Sirtuins and Resveratrol in Medicine
Papers in
- Co-authors
- John Michael Pezzuto (15 shared papers)Aiwen Jin (5 shared papers)Yanping Zhang (4 shared papers)Jerome W. Kosmeder (2 shared papers)Koji Itahana (3 shared papers)Sheila Ann Dugan (1 shared paper)Yoko Itahana (2 shared papers)Kenneth Aldape (12 shared papers)
- Journals
- Neuro-Oncology (11 papers)Cancer Cell (7 papers)Oncotarget (4 papers)Nature Medicine (3 papers)Frontiers in Oncology (3 papers)
- Partner nations
- United StatesSouth KoreaGermany
In The Last Decade
Krishna Bhat
80 papers receiving 9.9k citations
Krishna Bhat's Hit Papers
Peers
Comparison fields: 5 of 125
- Genetics 3.6k
- Geriatrics and Gerontology 512
- Oncology 1.7k
- Cancer Research 800
- Molecular Biology 2.6k
Countries citing papers authored by Krishna Bhat
This map shows the geographic impact of Krishna Bhat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krishna Bhat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krishna Bhat more than expected).
Fields of papers citing papers by Krishna Bhat
This network shows the impact of papers produced by Krishna Bhat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krishna Bhat. The network helps show where Krishna Bhat may publish in the future.
Co-authors
The 25 scholars most cited alongside Krishna Bhat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma Hit paper breakdown → | 2010 | 1945 |
| 2 | Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma Hit paper breakdown → | 2013 | 906 |
| 3 | 2003 | 467 | |
| 4 | 2001 | 447 | |
| 5 | 2016 | 381 | |
| 6 | 2003 | 376 | |
| 7 | 2001 | 347 | |
| 8 | 2002 | 330 | |
| 9 | Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance Hit paper breakdown → | 2023 | 311 |
| 10 | Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. | 2001 | 297 |
| 11 | 2007 | 257 | |
| 12 | 2004 | 218 | |
| 13 | 2007 | 197 | |
| 14 | 2005 | 182 | |
| 15 | 2019 | 180 | |
| 16 | 2010 | 177 | |
| 17 | 2021 | 165 | |
| 18 | 2018 | 162 | |
| 19 | 2019 | 160 | |
| 20 | 2015 | 153 |
About Krishna Bhat
Krishna Bhat is a scholar working on Genetics, Oncology, Cancer Research, Molecular Biology and Geriatrics and Gerontology, having authored 84 papers that have together received 10.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (44 papers), Cancer-related Molecular Pathways (5 papers), Estrogen and related hormone effects (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Cells and Metastasis (4 papers), Sirtuins and Resveratrol in Medicine (4 papers), Phytoestrogen effects and research (3 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Genetics (3.6k citations), Geriatrics and Gerontology (512 citations), Oncology (1.7k citations), Cancer Research (800 citations) and Molecular Biology (2.6k citations). Krishna Bhat has collaborated with scholars based in United States, South Korea and Germany. Frequent co-authors include John Michael Pezzuto, Aiwen Jin, Yanping Zhang, Jerome W. Kosmeder, Koji Itahana, Sheila Ann Dugan, Yoko Itahana, Kenneth Aldape, Yue Xiong and William Burkhart. Their work appears in journals such as Neuro-Oncology, Cancer Cell, Oncotarget, Nature Medicine and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.